Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cardiovasc Drugs Ther. 2013 Apr;27(2):10.1007/s10557-012-6436-7. doi: 10.1007/s10557-012-6436-7

Table 3.

Infarct data

Group N BW (kg) HW (g) Risk Zone (g) Infarct Size (g) IS/RZ (%)
Control* 14 2.8±0.2 14.0±0.8 2.54±0.29 1.37±0.23 49.3±3.9
OM2-pretreatment 6 2.4±0.1 13.3±0.8 2.20±0.34 0.85±0.25 33.4±7.3
OM2-reperfusion 5 2.2±0.1 11.1±0.7 1.83±0.14 0.55±0.13 28.8±5.2
Cangrelor 6 3.6±0.3 14.7±0.5 3.12±0.28 1.24±0.24 38.0±4.9

Abbreviations: BW = body weight HW = heart weight IS/RZ = ratio of infarct size to risk zone volume N = number of animals

*

Seven of these animals were reported in a prior publication [11].

Statistical significance of difference between experimental group and respective control:

p<0.01